Procurement Report: Sildenafil Citrate (Viagra)

Product Category: Prescription Medicinal Product (Pharmaceutical) Active Ingredient: Sildenafil Citrate Primary Indication: Treatment of Erectile Dysfunction (ED) and Pulmonary Arterial Hypertension (PAH)

Note: This report is generated for B2B procurement analysis of regulated pharmaceutical products. Sildenafil is a prescription-only medication in most jurisdictions. Procurement activities must strictly adhere to local laws, regulatory frameworks, and valid licensing requirements.

---

1. Technical Specifications and Performance Metrics

Sildenafil citrate is a phosphodiesterase type 5 (PDE5) inhibitor. Procurement specifications must align with the rigorous pharmacological profiles established by major regulatory bodies (e.g., EMA, FDA).

• Dosage Strengths: Standard commercial availability includes 25 mg, 50 mg, and 100 mg film-coated tablets. Emerging formulations include 50 mg orodispersible tablets and 50 mg orodispersible films.
• Onset of Action: Clinical data indicates a typical onset of action within 30 to 60 minutes post-administration.
• Duration of Effect: The therapeutic window typically lasts 4 to 5 hours, though individual metabolic rates vary.
• Bioavailability: Absolute bioavailability is approximately 41%.
• Half-Life ($t_{1/2}$): The elimination half-life is approximately 4 hours (range: 3–5 hours).
• Metabolism: Primarily metabolized by the hepatic cytochrome P450 system (CYP3A4 and CYP2C9).
• Packaging Durability: Standard pharmaceutical blister packs (PVC/Alu) offer a shelf life of 24 to 36 months when stored below 25°C. Orodispersible films require moisture-resistant packaging to maintain integrity.

Actionable Procurement Recommendation: When sourcing, verify that the batch specifications explicitly state the dissolution rate and assay purity (typically 98.0% to 102.0% of labeled amount). For orodispersible formats, demand specific disintegration time data (typically < 3 minutes in saliva) to ensure patient compliance. Do not procure generic formulations without a verified Certificate of Analysis (CoA) matching these pharmacokinetic profiles.

2. Industry Compliance and Quality Assurance

As a prescription pharmaceutical, Sildenafil is subject to strict global regulatory oversight. Procurement must prioritize suppliers with valid Marketing Authorization Holder (MAH) status.

• Regulatory Status: The product requires a Marketing Authorization Number (e.g., EU/1/98/077/xxx series) to be legally distributed in the European Union and similar frameworks in other regions.
• Manufacturing Standards: Facilities must comply with Good Manufacturing Practices (GMP) as defined by the EMA, FDA, or equivalent national authorities.
• Certification Requirements: Suppliers must provide valid GMP certificates and ISO 9001:2015 accreditation for quality management systems.
• Traceability: Full batch traceability is mandatory, with a requirement for serialization codes to prevent counterfeiting.
• Storage Compliance: Cold chain or controlled room temperature (15°C–25°C) logistics are required to maintain stability.

Actionable Procurement Recommendation: Before initiating any purchase order, conduct a Supplier Qualification Audit focusing on the validity of their Marketing Authorization Number and current GMP status. Reject any vendor unable to provide a current GMP certificate issued within the last 12 months. Ensure the contract includes a clause for immediate recall and regulatory reporting in the event of a quality deviation.

3. Cost Efficiency and Integration Capabilities

Note: Specific pricing data for prescription drugs is often opaque and varies significantly by region, volume, and reimbursement policies. The following figures represent typical B2B wholesale ranges.

• Unit Cost Range: Typical B2B wholesale pricing for branded Sildenafil citrate ranges from $0.50 to $2.50 USD per tablet (25mg–100mg), depending on volume and region.
• Minimum Order Quantity (MOQ): Standard pharmaceutical MOQs are typically 1,000 to 5,000 units per SKU to justify manufacturing runs.
• Lead Time: Standard lead time for international shipment is 4 to 8 weeks, accounting for customs clearance and regulatory documentation.
• Integration Capabilities: Modern supply chains utilize EDI (Electronic Data Interchange) for automated reordering. Integration with hospital pharmacy management systems (PMS) is standard for bulk buyers.
• Shelf-Life Management: Procurement strategies should prioritize "First-Expiry-First-Out" (FEFO) logistics to minimize waste.

Actionable Procurement Recommendation: Negotiate contracts based on volume tiers rather than fixed unit prices to secure better margins. Request a Just-in-Time (JIT) delivery schedule to reduce inventory holding costs, given the 24–36 month shelf life. Ensure the logistics partner has specific experience in pharmaceutical cold-chain or controlled-temperature transport to prevent degradation.

4. Typical Use Cases

• Primary Indication: Treatment of Erectile Dysfunction (ED) in adult males.
• Secondary Indication: Pulmonary Arterial Hypertension (PAH) (often under different brand names or dosing regimens, but same active ingredient).
• Target Demographic: Adult males (typically 18+), with increasing prevalence in the 40+ age group.
• Setting:
  • Retail Pharmacy: Over-the-counter (OTC) availability is restricted; requires prescription verification.
  • Hospital/Inpatient: Used in urology and cardiology departments.
  • Telemedicine: High demand for digital prescription fulfillment and discreet home delivery.
• Patient Profile: Patients with comorbidities such as diabetes, hypertension, or post-prostatectomy recovery.

Actionable Procurement Recommendation: Procurement strategies should align with telemedicine partnerships and retail pharmacy networks. For B2B buyers (e.g., hospital chains), prioritize suppliers capable of handling high-volume, consistent supply to avoid stock-outs during peak demand periods. Ensure packaging options include patient information leaflets in multiple languages if distributing across borders.

5. Long-Term Planning Considerations

• Market Trends: There is a growing demand for orodispersible formulations (films/tablets) due to improved patient compliance and faster onset.
• Demand Signals: Aging global populations are driving steady demand for ED treatments.
• Regulatory Shifts: Increasing scrutiny on generic competition and potential price controls in public healthcare systems.
• Supply Chain Resilience: Diversification of manufacturing sources is critical to mitigate risks from raw material shortages (e.g., sildenafil citrate API).
• Counterfeit Risk: The high value of the brand name makes it a target for counterfeiting; investment in anti-tamper packaging is essential.

Actionable Procurement Recommendation: Develop a multi-sourcing strategy involving at least two qualified manufacturers in different geographic regions to mitigate supply chain disruption risks. Plan for a product lifecycle transition by evaluating the adoption of newer orodispersible formats as the primary procurement line item in the next 3–5 years. Monitor regulatory changes regarding telemedicine prescriptions closely, as this will dictate the volume of direct-to-consumer shipments.

6. Special Product Recommendations

The following table compares standard and emerging formulations of Sildenafil citrate to assist in selecting the right product for specific procurement needs.

7. Frequently Asked Questions (FAQ)

Q1: What is the Minimum Order Quantity (MOQ) for Sildenafil citrate? A: Typical B2B MOQs range from 1,000 to 5,000 units per strength, depending on the manufacturer and whether the product is branded or generic.

Q2: How long is the shelf life of Sildenafil tablets? A: Standard film-coated tablets typically have a shelf life of 24 to 36 months when stored below 25°C. Orodispersible films may have slightly shorter stability windows depending on packaging.

Q3: Is Sildenafil available without a prescription? A: No. Sildenafil is a prescription-only medication in the vast majority of jurisdictions. Procurement requires valid licenses and verification of patient prescriptions.

Q4: What are the storage requirements for orodispersible films? A: These formulations are highly sensitive to moisture. They must be stored in hermetically sealed, moisture-resistant packaging and kept in a dry environment (typically <25°C).

Q5: How quickly does the drug take effect? A: Clinical data suggests an onset of action within 30 to 60 minutes after ingestion, with effects lasting up to 4–5 hours.

Q6: Can I import Sildenafil from another country? A: Importation is strictly regulated. You must possess a valid Marketing Authorization Number and comply with local customs and health authority regulations. Unauthorized importation is illegal.

Q7: What is the primary active ingredient? A: The active ingredient is Sildenafil Citrate, a specific PDE5 inhibitor.

Q8: Are there specific certifications required for the supplier? A: Yes, suppliers must hold valid GMP (Good Manufacturing Practice) certification and be the recognized Marketing Authorization Holder (MAH) or an authorized distributor with full traceability.